Your institution may have access to this item. Find your institution then sign in to continue.
Title
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
Authors
van Vollenhoven, Ronald F; Petri, Michelle A; Cervera, Ricard; Roth, David A; Ji, Beulah N; Kleoudis, Christi S; Zhong, Z John; Freimuth, William
Abstract
To identify factors that predict response to belimumab treatment in the phase 3 BLISS trials of autoantibody-positive systemic lupus erythematosus (SLE) and further analyse clinical efficacy in various patient subsets.
Publication
Annals of the rheumatic diseases, 2012, Vol 71, Issue 8, p1343